Searched for
VACCINE LICENSING DEAL
Chinese firm buys Canada mRNA Covid vaccine tech in $500 million dealWhile almost 1 billion people have been fully vaccinated in China, the country is still lacking an mRNA shot, with most of the population i...
WTO inches forward in Covid vaccine patent waiver talksViews on the matter meanwhile remain far apart, the trade official said, adding that an initial report on progress in the text-based discus...
Centre inks deal with Hyderabad-based Biological-E for second Made-In-India Covid shotThe vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry s...
Delhi floats global tender for 1 crore Covid-19 vaccine dosesIn the EOI, the Directorate General of Health Services (DGHS) stated that the offered vaccine must be duly approved by a competent authorit...
Government gears up for WTO patent battleAlthough India and South Africa’s joint proposal for a three-year TRIPS waiver for vaccines, drugs and equipment has been submitted, along ...
View: Mutual Nirbharta must to maximise vaccine manufacturing capacityIn this interdependent world, the research on a vaccine, its ingredients and its manufacturers are in different countries. India must never...
Use sovereign rights to grant compulsory license for vaccine, medicines: SJM to govt“We understand that the government needs to use the public health safeguards in the Patents Act and permit more companies to produce these ...
Why intellectual property waiver for vaccines is not so ’IP ’IP hooray at allThe more pertinent question, however, is whether the proposed TRIPs waiver, even if it is limited to only Covid vaccines, will boost vaccin...
Supreme Court wants Centre to ensure COVID-19 vaccines for all at low pricesThe top court asked the Centre for details about the grants made to Serum Institute of India (SII) and Bharat Biotech. It urged the Centre ...
Aurobindo Pharma set to make COVAXX's potential COVID-19 vaccine for India, UNICEFCOVAXX, a unit of privately-owned United Biomedical Inc, plans to pursue mid- and late-stage trials for the vaccine candidate from early 20...
Bharat Biotech's intranasal vaccine to enter phase I/II trials by month-endVaccine producer Bharat Biotech International (BBIL) could begin phase I/II human clinical trials for its single-dose intranasal vaccine ca...
Serum Institute to focus on supplying COVID-19 vaccine to India firstPoonawalla's comments came shortly after AstraZeneca said on Monday its vaccine could be around 90% effective, giving the world's fight aga...
Bangladesh signs deal with India for 30 million doses of COVID-19 vaccineBangladesh health minister Zahid Maleque said 5 million doses of vaccine per month would be purchased through Bangladesh's drug maker, Bexi...
Large pharma companies back appeal for TRIPS waiver for Covid-19 cure“We endorse the Indian government’s stand asking for a waiver of the TRIPS provisions to deal with the Covid-19 crisis. This is the time fo...
India and South Africa demand waiver of certain provisions of Intellectual Property for Covid-19 therapeuticsThis statement comes at a time when the race for Covid-19 vaccine is heating up across the world. Though most vaccine makers have received ...
Bilateral deals might not be equitable for Covid-19: MPP executive director Charles GoreThe Medicines Patent Pool is a United Nations-backed public health organisation that helps middle- and low-income countries get access to c...
Centre, ICMR to produce files relating to cancer drugs licenceThe Supreme Court directed the Centre to place before it the report of Parliamentary Standing Committee on Health and Family Welfare.